Synthesis of bridged palladium-PEPPSI complexes and catalytic studies in C–C cross-coupling reactions

A naphthalene-based heterobimetallic triazolylidene IrIII/PdII complex: regioselective to regiospecific C-H activation, tandem catalysis and a copper-free Sonogashira reaction

Heterobimetallic complexes featuring mesoionic carbene (MIC) donor ligands are gaining enormous popularity in tandem catalysis owing to the combined action of two different metal centers during catalysis. A rare version of the heterobimetallic Pd^II/Ir^III complex possessing a cyclometalated mesoionic carbene (MIC) ligand is presented along with the analogous homodinuclear Pd^II complex. A sterically controlled regiospecific cyclometalation towards the formation of a six-membered ring complex over a five-membered ring complex has been performed using a naphthalene-based bis-MIC ligand platform. The interplay between regioselective vs. regiospecific C-H bond activation for the synthesis of cyclometalated Ir^III complexes has also been demonstrated using the corresponding naphthyl-derived mono-imidazolylidene ligand. Both homodinuclear Pd^II and heterobimetallic Pd^II/Ir^III complexes have been characterized using standard spectroscopic techniques including ¹H, ¹³C{¹H}, 2D correlation NMR spectroscopy and ESI mass spectrometry. The structure of the cyclometalated heterobimetallic complex has been established by single crystal XRD. The heterobimetallic complex has been employed as a pre-catalyst in the tandem Suzuki-Miyaura/transfer hydrogenation reaction and the homobimetallic Pd^II complex has been successfully employed as a catalyst in both the Sonogashira coupling and α-arylation of 1-methyl-2-oxindole.

Molecular docking and in vitro anticancer studies of silver(I)-N-heterocyclic carbene complexes

A series of symmetric and unsymmetrical benzimidazolium-based N-heterocyclic carbene (NHC) precursors (1a-i) and their silver complexes (2a-i) have been synthesized. The Ag(I)–NHC complexes were characterized by ¹H, ¹³C{¹H} NMR, FTIR, LC/MS-QTOF, and elemental analysis. Anticancer and cytotoxic activity of all Ag(I)–NHC complexes were tested against healthy fibroblast cell line (L929), breast cancer cell line (MCF-7), and neuroblastoma cell line (SH-SY5Y) by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4sulfophenyl)-2H-tetrazolium] assay. The 2b, 2c, 2e, 2g, 2h, and 2i complexes showed higher cytotoxicity than cisplatin against SH-SY5Y and MCF-7 and lower cytotoxic activity against L929 cell lines. Because of their high cytotoxic activity against cancer cells and low cytotoxicity against healthy fibroblast cell lines, the 2b, 2c, 2e, 2g, 2h, and 2i are expected to be new lead compounds. In addition, molecular docking studies were performed to explore the binding interactions of silver complexes with the enzyme to explore new anticancer compounds. Furthermore, ADME properties of all complexes were predicted to explore lead-like characteristics and may be a potential drug candidate for cancer treatment.

Bimetallic PdII complexes with NHC/Py/PCy3 donor set ligands: applications in α-arylation, Suzuki–Miyaura and Sonogashira coupling reactions

Bimetallic PdII complexes bearing mixed NHC/Py/PCy3 donor set ligands are presented. A complex with a mixed NHC/PCy3 donor set ligands shows superior activity compared to the PEPPSI type complexes in α-arylation and Sonogashira coupling reactions.

Recent advances in NHC–palladium catalysis for alkyne chemistry: versatile synthesis and applications

This review summarizes the recent developments in NHC–palladium catalysis for alkyne chemistry: versatile synthesis and applications.

Pd-N-heterocyclic carbene complex catalysed C–H bond activation of 2-isobutylthiazole at the C5 position with aryl bromides

An effective and efficient catalytic system has been reported for the synthesis of C5-arylated 2-isobutylthiazoles.